FDA clears Ethicon’s 1st surgical set docs can assemble inside the body | Regulatory Roundup

Regulatory Roundup

Johnson & Johnson (NYSE:JNJ) Ethicon Endo-Surgery won FDA clearance for the 1st surgical instruments that can be assembled and disassembled inside the body during surgery.

Ethicon’s Percutaneous Surgical Set was cleared through the federal watchdog agency’ de novo pathway, a review process for low-to-moderate-risk medical devices that aren’t substantially equivalent to a product already on the market.

"Laparoscopic surgery reduces the size and number of incisions needed to perform certain surgical procedures," Christy Foreman, director of the Office of Device Evaluation in FDA’s Center for Devices & Radiological Health, said in prepared remarks. "The Percutaneous Surgical Set provides a novel treatment option for performing this type of abdominal procedure."

The surgical set was cleared only for use during minimally invasive laparoscopic abdominal surgery, during which surgeons insert a camera and instruments through a small incision in the body.

The surgical set is the 4th device cleared under the de novo process this year, according to a press release.

JNJ shares were down 0.1% to $65.16 as of about noon today.

 European resolutions post-breast implant scare raise eyebrows among device makers
European med-tech industry group Eucomed had "mixed feelings" about a series of resolutions introduced by European parliament members following the high-profile breast implant recall that may affect as many as 1 in 3 of the 30,000 women implanted with the recalled Poly Implant Prosthèse breast implants.

The device group was particularly wary of calls for a pre-market authorization system for Class II devices, given that regulations already require clinical data evaluation prior to marketing for all medical devices. Read more

 FDA grants PMA to Medinol’s Presillion coronary stent
Israel’s Medinol Ltd won FDA pre-market approval for its cobalt-chromium Presillion catheter-based coronary stent.

Medinol was previously mired in a coronary stent patent dispute with Natick, Mass.-based med-tech titan Boston Scientific (NYSE:BSX).  Read more

 Nephros lands 510(k) for Hemodiafiltration

River Edge, N.J.-based Nephros (OTC:NEPH) touted 510(k) clearance for its Hemodiafiltration system, designed as a complement to dialysis for patients with chronic renal failure.  Read more

 Toshiba touts FDA clearance for Aquilion Prime 80 CT system
Tustin, Calif.-based Toshiba America Medical Systems won FDA clearance for its Aquilion Prime 80 series, designed to produce high-quality clinical images while reducing radiation exposure.

The device giant also won clearance for its AIDR 3D dose-reduction imaging technology. Read more

 Theragenics scores FDA clearance for Market Galt valved tearaway introducer
Buford, Ga.-based Theragenics announced FDA clearance for its Market Galt valved tearaway introducer, designed for vascular access for catheter placement.   Read more

 Spectranetics wins FDA clearance for its GlideLight laser sheath
Colorado Springs, Colo.-based Spectranetics touted FDA clearance for its next-generation GlideLight laser sheath for removal of cardiac leads. The company plans to launch a limited market release before a broader controlled launch.   Read more

 ProPep Surgical lands CE Mark for 1st real-time nerve monitoring system for use during robotic surgery

 Hamilton Thorne wins FDA clearance for new Multi-Pulse software for clinical laser systems

 Insightra Medical lands CE Mark for next-gen fixation-free Freedom Inguinal Hernia System

 Vessix Vascular touts CE Mark for V2 renal denervation system for hypertension

 AcuFocus announces Korean Drug Admin. approval for its Kamra corneal inlay

 EndoSphere wins CE Mark for Satisphere duodenal insert as treatment for obesity

 Luminex scores CE Mark for xMap NeoPlex 4 assay and NeoPlex System for screening newborns

RSS From Medical Design & Outsourcing

  • Athermal laser machining cuts bioabsorbable polymers and more
    A the recent MD&M East trade show in New York, Norman Noble, discussed the capability of athermal laser manufacturer. The company has developed the Noble S.T.E.A.L.T.H. (System To Enable Ablation Laser Technology Haz-free). The athermal laser machining process was developed to create precise features in any material, including bioabsorbable polymers, shape memory metals and other […]
  • Exciting possibilities for metallic glass in the medical device world
    Researchers are exploring the potential of metallic glass as a versatile, pliable material that is stronger than steel, with a bevy of possible medical device applications. Yale University engineers have discovered a unique method for designing metallic glass nanostructures across a wide range of chemicals, a technique that could have applications for everything from watch […]
  • Strong Precision Technologies’ medical divisions to unify under MedTorque brand
    Strong Precision Technologies announced on July 2, 2015, that its two medical divisions will now go to market under a single brand, MedTorque. The move reflects the increasing integration of the division formerly known as Inland Midwest with MedTorque, its sister division in Kenosha, WI. “We will continue providing our customers with the personalized level of service […]
  • Olympus offers next-day product replacement guarantee for medical devices
    Olympus, a medical and surgical procedures solutions company, announced that it is guaranteeing next-day replacements for surgical equipment at no additional charge. Olympus is the first surgical product manufacturer to offer this type of guarantee. The service became available to customers with an Olympus Full Service Agreement earlier this year. “Canceled procedures can be costly for healthcare facilities […]
  • More accurate prediction on prognosis in multiple myeloma from SkylineDx
    SkylineDx, a biotechnology company specializing in the development and commercialization of genetic tests, is launching its MMprofiler assay. This test enables clinicians to more accurately predict the prognosis of patients with multiple myeloma (bone marrow cancer) than traditional methods. The MMprofiler measures the activity of 92 genes which are directly or indirectly related to the […]
  • Flint Mobile swaps card reader for camera, accept mobile payments anywhere
    Flint Mobile, the swipe-free mobile payments app, has significantly expanded its payment management and loyalty capabilities for small, service-centric businesses, like the ones run by on-the-go medical equipment professionals. The toggle-free mobile technology makes the process quite simple for both parties, as all transactions are conducted through the mobile device’s camera without the need of any external […]
  • Should scientists be allowed to genetically alter human embryos?
    Scientists have at their disposal, a way to explore the possible prevention of genetic diseases before birth. But should they? Currently, the most promising path forward involves editing the genes of human embryos, a procedure threaded with controversy. An article in “Chemical & Engineering News” (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), parses […]
  • Tackling chronic sinusitis by addressing underlying factors
    The stuffy noses and sinus pressure of head colds are uncomfortable, but for most people, they go away within days. For those with chronic sinusitis, however, those symptoms and others drag on for weeks. Now scientists are onto a potential new therapy that could address one of the underlying factors associated with the condition. They […]
  • Implantable “artificial pancreas” could help diabetes patients control their blood sugar
    Living with Type 1 diabetes requires constant monitoring of blood sugar levels and injecting insulin daily. Now scientists are reporting in the American Chemical Society (ACS) journal, “Industrial & Engineering Chemistry Research,” the development of an implantable “artificial pancreas” that continuously measures a person’s blood sugar or glucose level and can automatically release insulin as […]
  • Drug Deactivation program roll out to all facilities for safe disposal of unused prescription medications
    Verde Technologies announced that New Brighton-based Meridian Behavioral Health, the largest for-profit substance abuse and addiction treatment group in Minnesota, has become its most recent partner in the deactivation and safe disposal of prescription medications including methadone. Meridian is the first behavioral health group to roll out the Deterra Drug Deactivation System to all 17 […]
  • Lophius Biosciences introduces T-activated ImmunoScan Cocktail
    Lophius Biosciences announced the commercial launch of T-Track ImmunoScan and T-activated ImmunoScan Cocktail. Based on a proprietary and very specific cocktail of stimulants in combination with the Company’s T-activation technology, T-Track ImmunoScan and T-activated ImmunoScan Cocktail specifically target different cell types involved in both the adaptive and innate immune system. T-Track ImmunoScan and the T-activated […]

Leave a Reply